Enhances fat metabolism and energy production, potentially boosting the weight loss efficacy of GLP-1 agonists
Here are five key takeaways from ECRIs clinical evidence research: GLP-1 RAs are effective to achieve additional, clinically significant weight loss in adolescents and adults with obesity or overweight, as indicated by FDA-approved labeling, and who are committed to achieving weight loss through lifestyle changes (i.e., diet, exercise)
Supplementary material The Supplementary Material for this article can be found online at: References 1 TalbotKWangH-Y
For patients taking blood pressure medications, healthcare providers often need to adjust their prescriptions, as many individuals require less anti-hypertensive medication following semaglutide treatment
Gastroenterology, 160 (3), 783-795